Charm Therapeutics
Charm is using deep-learning models via its proprietary platform, DragonFold, to predict the co-crystal structure of a protein-ligand complex based on a protein's primary sequence and the ligand’s chemical structure.
London, UKcharmtx.com ↗
Total raised
€116M
€116,028,736
Funding rounds
2
Investors
9
distinct backers
Active since
2022-06
latest 2025-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood59
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood17
base rate 12% (2+ rounds)
- ▲ €100M+ raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-02 | Series B | €68M | F-Prime Capital,Khosla Ventures,New Enterprise Associates (NEA),NVIDIA,OrbiMed,SR One | View deal → |
| 2022-06-10 | Series A | €48M | Axial,Braavos Capital,F-Prime Capital,General Catalyst,Khosla Ventures,OrbiMed | View deal → |